About Diesse Diagnostica Senese
Diesse Diagnostica Senese is a company based in Milano (Italy) founded in 1982 was acquired by Fremman in July 2025.. Diesse Diagnostica Senese offers products and services including VES-MATIC ESR line, CHORUS Automated Immunochemistry, AUTO-DAT Agglutination, ENZYWELL Manual Immunochemistry, and iRAPID Immuno Rapid Diagnostics. Diesse Diagnostica Senese operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Milano, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diesse Diagnostica Senese S.P.A. Societa Benefit
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
European Commission
& 2 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diesse Diagnostica Senese
Diesse Diagnostica Senese offers a comprehensive portfolio of products and services, including VES-MATIC ESR line, CHORUS Automated Immunochemistry, AUTO-DAT Agglutination, ENZYWELL Manual Immunochemistry, and iRAPID Immuno Rapid Diagnostics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated tool for measuring erythrocyte sedimentation rate in blood samples.
Multi-parameter system for random access immunoassays using ready-to-use devices.
System to standardize and expedite seroagglutination tests in microplates.
Manual kits for immunochemistry testing and diagnostics.
Rapid immuno diagnostic tools for various clinical conditions.
Funding Insights of Diesse Diagnostica Senese
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Grant - Diesse Diagnostica Senese | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diesse Diagnostica Senese
Diesse Diagnostica Senese has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, Fremman Capital and ARCHIMED. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare industries are funded and supported globally by ARCHIMED.
|
Founded Year | Domain | Location | |
|
Institution of the European Union responsible for upholding the EU treaties
|
Founded Year | Domain | Location | |
|
Fremman Capital is engaged in lower mid-market investments across Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diesse Diagnostica Senese
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diesse Diagnostica Senese
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diesse Diagnostica Senese Comparisons
Competitors of Diesse Diagnostica Senese
Diesse Diagnostica Senese operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Diesse Diagnostica Senese
Frequently Asked Questions about Diesse Diagnostica Senese
When was Diesse Diagnostica Senese founded?
Diesse Diagnostica Senese was founded in 1982 and raised its 1st funding round 33 years after it was founded.
Where is Diesse Diagnostica Senese located?
Diesse Diagnostica Senese is headquartered in Milano, Italy.
What does Diesse Diagnostica Senese do?
DIESSE Diagnostica Senese develops instruments and assay kits for infectious disease diagnostics and clinical chemistry. It has the VES-MATIC CUBE instrument range for automated quantification of erythrocyte sedimentation rate, which includes a point-of-care version called miniCUBE, the Chorus TRIO for automation of immunometric assays, and the Plus Finder for automated analysis of microbial cultures for rapid screening of bacteriuria. In addition, the company also has associated reagents and kits for its instrument line, as well as ELISA kits and rapid point-of-care assays. Applications include diagnosis of chikungunya, cytomegalovirus, Epstein Barr Virus, Helicobacter pylori, herpes, influenza, measles, mumps, pneumonia, parvovirus, rubella, syphilis, toscana virus, toxoplasma and varicella. Rapid tests include diagnostics for mononucleosis, syphilis, and streptococcus.
Who are the top competitors of Diesse Diagnostica Senese?
Diesse Diagnostica Senese's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does Diesse Diagnostica Senese offer?
Diesse Diagnostica Senese offers VES-MATIC ESR line, CHORUS Automated Immunochemistry, AUTO-DAT Agglutination, ENZYWELL Manual Immunochemistry, and iRAPID Immuno Rapid Diagnostics.
Who are Diesse Diagnostica Senese's investors?
Diesse Diagnostica Senese has 3 investors. Key investors include European Commission, Fremman Capital, and ARCHIMED.